Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment

Atherosclerosis. 1997 Mar 21;129(2):169-76. doi: 10.1016/s0021-9150(96)06022-4.

Abstract

To evaluate the role of both oxidation and inflammation in atherosclerosis, we compared LDL oxidizability, in vivo lipid and cholesterol oxidation, and basal and lipopolysaccharide (LPS)-stimulated production of various cytokines in normolipidemic patients with diabetes mellitus (DM: n = 11), cigarettes smokers (n = 14). In addition, the effects of vitamin E (600 I.U./day for 4 weeks) on these parameters were evaluated. Initial LDL oxidation characteristics before and after vitamin E were identical in the 3 groups. Plasma thiobarbituric acid reactive substances were higher in DM and smokers versus controls (0.77 +/- 0.22, 0.74 +/- 0.14 versus 0.62 +/- 0.10 mumol malondialdehyde equivalents/l, respectively; P versus controls < 0.05) and normalized after vitamin E supplementation. Total plasma oxysterols were higher in smokers versus controls (354 +/- 104 versus 265 +/- 66 nmol/l, P < 0.05) and unaffected by vitamin E. The basal and LPS-stimulated levels of interleukin-1 beta and tumour necrosis factor alpha (TNF alpha) and the basal level of interleukin-1-receptor antagonist (IL-1RA) were identical for the 3 groups. LPS-stimulated IL-1RA was higher in DM versus controls (10.7 +/- 2.0 versus 8.1 +/- 1.7 pmol/l, P < 0.05). After vitamin E, TNF alpha dropped in controls and smokers, and IL-1RA in smokers only. Results suggest increased in vivo oxidative stress and inflammation in DM and smoking, which is partly overcome by vitamin E.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cholesterol / blood*
  • Cholesterol Esters / blood
  • Cytokines / blood*
  • Diabetes Mellitus / blood*
  • Female
  • Humans
  • Inflammation
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / blood
  • Lipid Peroxidation
  • Lipids / blood*
  • Lipopolysaccharides / pharmacology
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Oxidative Stress
  • Sialoglycoproteins / blood
  • Smoking / blood*
  • Thiobarbituric Acid Reactive Substances / analysis
  • Tumor Necrosis Factor-alpha / analysis
  • Vitamin E / pharmacology*
  • Vitamin E / therapeutic use

Substances

  • Cholesterol Esters
  • Cytokines
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Lipids
  • Lipopolysaccharides
  • Sialoglycoproteins
  • Thiobarbituric Acid Reactive Substances
  • Tumor Necrosis Factor-alpha
  • Vitamin E
  • Cholesterol